Back to CRVS

ORBIMED ADVISORS LLC → CRVS

ORBIMED ADVISORS LLC CRVS Position History

Corvus Pharmaceuticals, Inc. • Healthcare

Quarters held
4
Latest value
$82.5M
Q3 2026
Peak value
$107M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$55.2M
Q1 2026$104.8M
Q2 2026$107M
Q3 2026$82.5M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$82.5M7.17M——
Q2 2026$107M7.17M——
Q1 2026$104.8M7.17M——
Q4 2025$55.2M7.17M——

Other funds holding CRVS

Other ORBIMED ADVISORS LLC positions

EWTX

EDGEWISE THERAPEUTICS INC

$630.5M
EWTX

EDGEWISE THERAPEUTICS INC

$630.1M
EWTX

EDGEWISE THERAPEUTICS INC

$488.8M
ADRX

ADARX PHARMACEUTICALS INC

$482.7M
EWTX

EDGEWISE THERAPEUTICS INC

$385.1M
ELVN

ENLIVEN THERAPEUTICS INC

$343.9M
LLY

ELI LILLY & CO

$323.7M
ELVN

ENLIVEN THERAPEUTICS INC

$312M